<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01047982</url>
  </required_header>
  <id_info>
    <org_study_id>INOGDM-2010</org_study_id>
    <nct_id>NCT01047982</nct_id>
  </id_info>
  <brief_title>Myo-inositol in Obese Pregnant Women</brief_title>
  <official_title>Myo-inositol May Prevent Gestational Diabetes in Obese Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Messina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Messina</source>
  <brief_summary>
    <textblock>
      Myo-Inositol is classified as a member of the vitamin B complex. It is a constituent of
      living cells and is widespread in many food. It is involved in a number of biological
      processes, including insulin signal transduction, resulting in modulating insulin
      sensitivity. This is a prospective, randomized, double center, placebo-controlled study. Two
      hundred and twenty obese pregnant women will be included in the trial and, after an informed
      consent, will assume randomly 2 g of myo-inositol twice a day or placebo from 12-13th weeks
      gestation until delivery. Then,they will perform an Oral Glucose Tolerance Test (OGTT) at
      24-28th weeks gestation. Records about delivery (gestational age, neonatal weight...) will be
      registered.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2010</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">July 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>number of gestational diabetes cases diagnosed with OGTT</measure>
    <time_frame>24-28th weeks gestation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>difference in HOMA values</measure>
    <time_frame>from first trimester to OGTT</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>incidence of pregnancy complications: hypertension, preterm delivery. macrosomia, shoulder dystocia, etc.</measure>
    <time_frame>at delivery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">220</enrollment>
  <condition>Gestational Diabetes</condition>
  <arm_group>
    <arm_group_label>myo-inositol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>acid folic 400 mcg twice per day</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>myo-inositol</intervention_name>
    <description>myo-inositol 2 grams plus folic acid 400 mcg twice a day</description>
    <arm_group_label>myo-inositol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>folic acid 400 mcg</intervention_name>
    <description>2 pills a day</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Obese pregnant women: BMI &gt; 30 Kg/cm2

          -  first trimester fast glycaemia &lt; 126 mg/dl

          -  single pregnancy

        Exclusion Criteria:

          -  Pregnant women with BMI &lt; 30 Kg/cm2

          -  first trimester fast glycaemia &gt; 126 mg/dl

          -  previous gestational diabetes

          -  twin pregnancy

          -  pregestational diabetes

          -  associated therapies with corticosteroids
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rosario D'Anna, professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Messina, ITALY</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Obstetrics and Gynecology Unit, University of Messina and Obstetrics and Gynecology Unit of Modena University</name>
      <address>
        <city>Messina and Modena</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 12, 2010</study_first_submitted>
  <study_first_submitted_qc>January 12, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 13, 2010</study_first_posted>
  <last_update_submitted>February 27, 2014</last_update_submitted>
  <last_update_submitted_qc>February 27, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 28, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Messina</investigator_affiliation>
    <investigator_full_name>Rosario D'anna</investigator_full_name>
    <investigator_title>associate professor</investigator_title>
  </responsible_party>
  <keyword>gestational diabetes</keyword>
  <keyword>macrosomia</keyword>
  <keyword>hypertension in pregnancy</keyword>
  <keyword>HOMA-IR</keyword>
  <keyword>obesity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes, Gestational</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Folic Acid</mesh_term>
    <mesh_term>Vitamin B Complex</mesh_term>
    <mesh_term>Inositol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

